Dynamic MapReport

World News   USA   California   Bay Area   San Francisco   North San Mateo County   South SF   Business (48)
South SF, Business Timeline Sunday, June 17 Bookmark and Share     Author
Search Bay Area News Atlas:
World News (13) World Business (847) USA (336) California (187) Bay Area (13) Bay Area Business (1699) San Francisco (2215) North San Mateo County (177) South SF (135) Accidents (61) Politics (6) Crime (64) Sports Science & Education (15) Business (48)
Healthcare Business (1) Retail (3) Lottery (2) Merger and Acquisition (12) Bio Tech (17) Genentech Food (1) Public Transportation (1) IPO (4) Business Leaders (2) Business Resignation (2) Job Cut (2) Earnings (1) 1st Quarter Earnings (2) 4th Quarter Earnings (2) High Tech Business (1) Stocks (1) Business Lawsuit (2) Lawsuit Settled (3) Patent Suit (3) Avastin (14) Roche (16) Herceptin (3) Cancer Drug Sales (2) Tanox (2) Rituxan (2) Lucentis (2)
2017 (1) 2015 (1) 2014 (2) 2013 (3) 2012 (2) 2011 (3) 2010 (4) 2009 (14) 2008 (11) 2007 (1) 2006 (2) 2005 (1) 2003 (1) 2002 (2)
South SF Business on Wikipedia South SF Business on Web

Chart
Oakland Downtown Public Transportation (6)   Roche (16)   Genentech Business   Avastin (14)   Cancer (64)

Bad Economic News Main Event: New ferry serv...
South San Francisco on Google Map

1. 2017-01-01 Fire damages medical clinic, business in South San Francisco El Camino Real and Westborough Boulevard, South SF
C. 2015-07-25 Woman wins $5 million with Scratcher 2255 Gellert Boulevard, South SF
D. 2014-07-02 Genentech to buy Seragon Pharmaceuticals Genentech
E. 2014-03-17 Biotech deal could mean $350 million for Five Prime Therapeutics South SF
5. 2013-10-18 South San Francisco Costco recalls more chicken Costco, South SF
G. 2013-10-14 Genentech invests $285 million in biotech in state Genentech
2012-06-04 New ferry service launches with free rides Alameda
8. 2012-04-25 Envivio falls on Wall Street after IPO South SF

Recent Summary.     Click for More >
No news/event found



    
    


Add a favorite (file a bookmark) to South SF, Business Timeline



Please send feedback to: support@mapreport.com

Advertise on South SF, Business Page

Legend  

XML

Details:

Fire damages medical clinic, business in South San Francisco. 94080 Woman wins $5 million with Scratcher. 94080 Genentech to buy Seragon Pharmaceuticals Biotech deal could mean $350 million for Five Prime Therapeutics South San Francisco Costco recalls more chicken. 94080 Genentech invests $285 million in biotech in state Amgen to Buy Onyx for $10.4 Billion to Gain Cancer Drug  Amgen Inc. agreed to buy Onyx Pharmaceuticals Inc. in a $10.4 billion to give Amgen access to a rapidly expanding cancer-drug market New ferry service launches with free rides


year 2017 Top ^

Jan.1


year 2015 Top ^

Jul.25


year 2014 Top ^

Jul.2
Mar.17


year 2013 Top ^

Oct.18
Oct.14
Aug.27


year 2012 Top ^

Jun.4
  Alameda: Commuters can hop aboard in Alameda or Jack London Square. About 40 minutes later they will arrive at the new Oyster Point Ferry terminal in South SF
Apr.25 Envivio falls on Wall Street after IPO

year 2011 Top ^

Dec.28 Solazyme CEO resigns
Nov.15 Apple names Levinson non-exec chair  Apple rewards the longtime Apple board member who chose it over Google when the technology giants began competing May.27 Solazyme's solid IPO  Startup that makes algae-based biofuel, raised nearly $200 million; the stock finished on the Nasdaq at $20.71 with a 15% gain

year 2010 Top ^

Nov.18 Genentech cutting 450 jobs in South SF
Jul.20 Panel doesn't back Avastin for cancer. Genentech Jul.2 Avastin delays ovarian cancer. Genentech Jan.9 FDA Approves Actemra Arthritis Drug. Genentech

year 2009 Top ^

Nov.11 Jackpot Lottery Ticket Sold
Aug.2 FDA clears drug for kidney cancer  Genentech: Food and Drug Administration approved its cancer treatment Avastin for a new use, marking the sixth approval for the blockbuster drug Jul.9 Axe falls at Genentech
  Anxiety rippled through Genentech as Roche began to cut rank-and-file jobs as it folds the South SF biotech firm into its global operations Apr.15 Big leadership changes at Genentech Apr.8 Drug Raptiva pulled from market  Genentech: The unit of drugmaker Roch is pulling the psoriasis treatment Raptiva off the U.S. market because of links to an often fatal brain infection Mar.26 Roche completes purchase of Genentech Mar.12 Roche to take over Genentech for $47B
  Swiss giant agreed to buy the 44% of biotech pioneer that it doesn't already own, ending a long corporate struggle
 The $95-per-share deal brings Roche all of the sales of cancer drugs as well as its promising research pipeline. The deal offers $95 per share for the 44 percent of Genentech that Roche Holding AG doesn't already own
Mar.9 Roche-Genentech deal called close  Roche is reportedly willing to pay Genentech $95 a share, up from the $93, in what would be a $46.7 billion deal Mar.6 Roche raises bid for Genentech  Swiss drugmaker increased its offer to $93 per share. Genentech shares shot up to $90.05, gaining $8.41 or 10 percent Mar.3 Genentech replies to hostile Roche bid Feb.9 Roche launches $86.50-a-share bid  Genentech: Swiss drugmaker officially launched its $42 billion hostile offer for the 44% of Genentech Inc. it doesn't already own Feb.6 Roche CEO: Offer for Genentech fair deal Jan.30 Roche revives takeover bid of Genentech  Swiss drugmaker, frustrated by stalled negotiations, plans a hostile takeover at a lower price than the $89 per share rejected in August Jan.18 Cell Genesys delisting reprieve extended

year 2008 Top ^

Dec.12 Bristol-Myers joins Exelixis for drugs
Nov.18 Avastin linked to higher risk of clots  Genentech: A team of university researchers: Blockbuster cancer drug is linked to a significantly increased risk of blood clots in the veins Sep.25 Fluidigm Withdraws IPO Sep.19 Fluidigm pushing forward with IPO Sep.9 Solazyme producing oil from algae  The startup said that it had produced the world's first algal-derived jet fuel and had passed 11 tests necessary for use in aviation Aug.27 Cell Genesys Drug Trial Halts  Shares plunged more than 70% after a clinical trial of its cancer vaccine Gvax was stopped due to a higher number of deaths among patients Aug.13 Genentech rejects Roche's $43.7b bid  Biotechnology giant rejected a buyout offer from its majority owner Roche but said it is open to a higher takeover bid Jul.21 Roche Offers $44B For Remaining Shares  Genentech: Roche Holding, which already owns 55.9%, was offering $43.7 billion to take over the remaining shares of Genentech Apr.30 Bad news on cancer drug Rituxan  Genentech: Shares in Genentech sagged, after the company said Rituxan failed to curb symptoms of the debilitating autoimmune disorder Apr.24 Court slashes $200 million from judgment  Genentech: The company has been ordered to pay $500 million to a Southern California hospital for failing to pay royalties Feb.22 FDA Clears Avastin for Breast Cancer
  Genentech: A Genentech drug received federal approval, a surprise decision


year 2007 Top ^

Dec.5 FDA Panel Rejects Avastin, stock drops  Genentech: Shares dropped nearly 9% after a panel of medical experts said FDA should deny approval of the company's blockbuster drug

year 2006 Top ^

Jul.31 Tony Blair Visits Genentech Headquarters Feb.13 Cancer Drug Trials Scaled Back. Genentech

year 2005 Top ^

Jul.11 Profits Soar 73% in 2Q
. Genentech

year 2003 Top ^

May.19 Encouraging results with cancer drug
  Genentech: Avastin extended the lives of some of the colon cancer patients. Company's stock soaring nearly 45%


year 2002 Top ^

Sep.7 Big patent win vs. Chiron. Genentech Aug.26   Lotto winner stepped forward
  The 43-year-old grandmother Cindy Blair will share the $120 million-dollar pot with three other winners



Court slashes $200 million from judgment  Genentech: The company has been ordered to pay $500 million to a Southern California hospital for failing to pay royalties Big patent win vs. Chiron. Genentech Woman wins $5 million with Scratcher. 94080 Jackpot Lottery Ticket Sold Lotto winner stepped forward




South SF, Business Business Lawsuit Timeline ... See Bay Area Business Lawsuit timeline, World Business Lawsuit timeline Top ^
2008
Apr.24
2002
Sep.7




South SF, Business Retail Timeline ... See Bay Area Retail timeline, World Retail timeline Top ^
2015
Jul.25
2009
Nov.11
2002
Aug.26
  The 43-year-old grandmother Cindy Blair will share the $120 million-dollar pot with three other winners




South SF, Business Food Timeline ... See Bay Area Food timeline, World Food timeline Top ^
2013 Oct.18 South San Francisco Costco recalls more chicken. 94080



South SF, Business Public Transportation Timeline ... See Bay Area Public Transportation timeline, World Public Transportation timeline Top ^
2012 Jun.4 New ferry service launches with free rides
  Alameda: Commuters can hop aboard in Alameda or Jack London Square. About 40 minutes later they will arrive at the new Oyster Point Ferry terminal in South SF




South SF, Business Merger and Acquisition Timeline ... See Bay Area Merger and Acquisition timeline, World Merger and Acquisition timeline Top ^
2014 Jul.2 Genentech to buy Seragon Pharmaceuticals 2013 Aug.27 Amgen to Buy Onyx for $10.4 Billion to Gain Cancer Drug
  Amgen Inc. agreed to buy Onyx Pharmaceuticals Inc. in a $10.4 billion to give Amgen access to a rapidly expanding cancer-drug market 2009 Apr.15 Big leadership changes at Genentech Mar.26 Roche completes purchase of Genentech Mar.12 Roche to take over Genentech for $47B
  Swiss giant agreed to buy the 44% of biotech pioneer that it doesn't already own, ending a long corporate struggle
 The $95-per-share deal brings Roche all of the sales of cancer drugs as well as its promising research pipeline. The deal offers $95 per share for the 44 percent of Genentech that Roche Holding AG doesn't already own
Mar.9 Roche-Genentech deal called close  Roche is reportedly willing to pay Genentech $95 a share, up from the $93, in what would be a $46.7 billion deal Mar.6 Roche raises bid for Genentech  Swiss drugmaker increased its offer to $93 per share. Genentech shares shot up to $90.05, gaining $8.41 or 10 percent Mar.3 Genentech replies to hostile Roche bid Feb.9 Roche launches $86.50-a-share bid  Genentech: Swiss drugmaker officially launched its $42 billion hostile offer for the 44% of Genentech Inc. it doesn't already own Feb.6 Roche CEO: Offer for Genentech fair deal Jan.30 Roche revives takeover bid of Genentech  Swiss drugmaker, frustrated by stalled negotiations, plans a hostile takeover at a lower price than the $89 per share rejected in August 2008 Aug.13 Genentech rejects Roche's $43.7b bid  Biotechnology giant rejected a buyout offer from its majority owner Roche but said it is open to a higher takeover bid



South SF, Business Business Leaders Timeline ... See Bay Area Business Leaders timeline, World Business Leaders timeline Top ^
2011 Dec.28 Solazyme CEO resigns
Nov.15 Apple names Levinson non-exec chair
  Apple rewards the longtime Apple board member who chose it over Google when the technology giants began competing



South SF, Business Bio Tech Timeline ... See Bay Area Bio Tech timeline, World Bio Tech timeline Top ^
2014 Mar.17 Biotech deal could mean $350 million for Five Prime Therapeutics
2013 Oct.14 Genentech invests $285 million in biotech in state 2010 Jul.20 Panel doesn't back Avastin for cancer. Genentech Jul.2 Avastin delays ovarian cancer. Genentech Jan.9 FDA Approves Actemra Arthritis Drug. Genentech 2009 Aug.2 FDA clears drug for kidney cancer  Genentech: Food and Drug Administration approved its cancer treatment Avastin for a new use, marking the sixth approval for the blockbuster drug Apr.8 Drug Raptiva pulled from market  Genentech: The unit of drugmaker Roch is pulling the psoriasis treatment Raptiva off the U.S. market because of links to an often fatal brain infection 2008 Dec.12 Bristol-Myers joins Exelixis for drugs Nov.18 Avastin linked to higher risk of clots  Genentech: A team of university researchers: Blockbuster cancer drug is linked to a significantly increased risk of blood clots in the veins Aug.27 Cell Genesys Drug Trial Halts  Shares plunged more than 70% after a clinical trial of its cancer vaccine Gvax was stopped due to a higher number of deaths among patients Apr.30 Bad news on cancer drug Rituxan  Genentech: Shares in Genentech sagged, after the company said Rituxan failed to curb symptoms of the debilitating autoimmune disorder Feb.22 FDA Clears Avastin for Breast Cancer
  Genentech: A Genentech drug received federal approval, a surprise decision
2007 Dec.5 FDA Panel Rejects Avastin, stock drops  Genentech: Shares dropped nearly 9% after a panel of medical experts said FDA should deny approval of the company's blockbuster drug 2006 Jul.31 Tony Blair Visits Genentech Headquarters Feb.13 Cancer Drug Trials Scaled Back. Genentech 2005 Jul.11 Profits Soar 73% in 2Q. Genentech 2003 May.19 Encouraging results with cancer drug
  Genentech: Avastin extended the lives of some of the colon cancer patients. Company's stock soaring nearly 45%




South SF, Business Stocks Timeline ... See Bay Area Stocks timeline, World Stocks timeline Top ^
2008 Jul.21 Roche Offers $44B For Remaining Shares  Genentech: Roche Holding, which already owns 55.9%, was offering $43.7 billion to take over the remaining shares of Genentech



South SF, Business Healthcare Business Timeline ... See Bay Area Healthcare Business timeline, World Healthcare Business timeline Top ^
2017 Jan.1 Fire damages medical clinic, business in South San Francisco. 94080



South SF, Business Earnings Timeline ... See Bay Area Earnings timeline, World Earnings timeline Top ^
2009 Jan.18 Cell Genesys delisting reprieve extended




South SF, Business Job Cut Timeline ... See Bay Area Job Cut timeline, World Job Cut timeline Top ^
2010 Nov.18 Genentech cutting 450 jobs in South SF
2009 Jul.9 Axe falls at Genentech  Anxiety rippled through Genentech as Roche began to cut rank-and-file jobs as it folds the South SF biotech firm into its global operations



South SF, Business High Tech Business Timeline ... See Bay Area High Tech Business timeline, World High Tech Business timeline Top ^
2008 Sep.9 Solazyme producing oil from algae  The startup said that it had produced the world's first algal-derived jet fuel and had passed 11 tests necessary for use in aviation



South SF, Business IPO Timeline ... See Bay Area IPO timeline, World IPO timeline Top ^
2012 Apr.25 Envivio falls on Wall Street after IPO
2011 May.27 Solazyme's solid IPO  Startup that makes algae-based biofuel, raised nearly $200 million; the stock finished on the Nasdaq at $20.71 with a 15% gain 2008 Sep.25 Fluidigm Withdraws IPO Sep.19 Fluidigm pushing forward with IPO